Cargando…
Inhibitors of the renin–angiotensin system and SARS-CoV-2 infection
Autores principales: | Kessler, Thorsten, Schunkert, Heribert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142323/ https://www.ncbi.nlm.nih.gov/pubmed/32274522 http://dx.doi.org/10.1007/s00059-020-04920-4 |
Ejemplares similares
-
The Renin-Angiotensin System, Hypertension, and SARS-CoV-2 Infection: a Review
por: Gathiram, Premjith, et al.
Publicado: (2021) -
Drugs acting on the renin–angiotensin system and SARS-CoV-2
por: Vitiello, Antonio, et al.
Publicado: (2021) -
Modeling the Molecular Impact of SARS-CoV-2 Infection on the Renin-Angiotensin System
por: Pucci, Fabrizio, et al.
Publicado: (2020) -
SARS-CoV-2 Infection in Asymptomatic Patients Hospitalized for Cardiac Emergencies: Implications for Patient Management
por: Kessler, Thorsten, et al.
Publicado: (2020) -
Outcomes of hospitalized patients with SARS-CoV-2 infection previously treated with renin-angiotensin system inhibitors
por: Cordeanu, E., et al.
Publicado: (2021)